Isodesmosine

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 909 Experts worldwide ranked by ideXlab platform

Toyonobu Usuki - One of the best experts on this subject based on the ideXlab platform.

  • Preparation of Isodesmosine‐KLH conjugate for ELISA system
    Chirality, 2020
    Co-Authors: Daria A. Baut, Nao Tanaka, Reiko Yokoo, Toyonobu Usuki
    Abstract:

    Chronic obstructive pulmonary disease (COPD) is a degenerative condition with limited diagnostic detection efficiency. Currently with no available cure, COPD is associated with irreversible elastic tissue degradation in lungs, which results in release of unusual amino acids, Isodesmosine and desmosine. These biomarkers are potential key elements in enzyme-linked immunosorbent assay (ELISA), an analytical method, which can detect certain compounds including antigens and proteins in easy and affordable manner. In order to target a biomarker with ELISA, it is necessary to prepare its specific antibody, which can be achieved by immunization of host organism with appropriate antigen containing the biomarker. Although preparation of these types of conjugates has been published, desmosine and Isodesmosine used by researchers are obtained from natural sources such as animal tissues. Here, we report the first synthetic preparation of Isodesmosine and keyhole limpet hemocyanin (KLH) conjugate from commercially available chiral amino acids and carrier protein. Formation of the core pyridinium of Isodesmosine was achieved through key reaction-Chichibabin pyridinium synthesis-to deliver a 1,2,3,5-tetrasubstituted pyridinium amino acid selectively. Further modifications involving KLH and maleimide linker provided the target conjugate, which could potentially invoke an immune response to produce anti-Isodesmosine antibody for the ELISA system.

  • preparation of Isodesmosine klh conjugate for elisa system
    Chirality, 2020
    Co-Authors: Daria A. Baut, Nao Tanaka, Reiko Yokoo, Toyonobu Usuki
    Abstract:

    Chronic obstructive pulmonary disease (COPD) is a degenerative condition with limited diagnostic detection efficiency. Currently with no available cure, COPD is associated with irreversible elastic tissue degradation in lungs, which results in release of unusual amino acids, Isodesmosine and desmosine. These biomarkers are potential key elements in enzyme-linked immunosorbent assay (ELISA), an analytical method, which can detect certain compounds including antigens and proteins in easy and affordable manner. In order to target a biomarker with ELISA, it is necessary to prepare its specific antibody, which can be achieved by immunization of host organism with appropriate antigen containing the biomarker. Although preparation of these types of conjugates has been published, desmosine and Isodesmosine used by researchers are obtained from natural sources such as animal tissues. Here, we report the first synthetic preparation of Isodesmosine and keyhole limpet hemocyanin (KLH) conjugate from commercially available chiral amino acids and carrier protein. Formation of the core pyridinium of Isodesmosine was achieved through key reaction-Chichibabin pyridinium synthesis-to deliver a 1,2,3,5-tetrasubstituted pyridinium amino acid selectively. Further modifications involving KLH and maleimide linker provided the target conjugate, which could potentially invoke an immune response to produce anti-Isodesmosine antibody for the ELISA system.

  • Preparation of Protected 13Cn-Labeled Isodesmosines: Mechanistic Insight of Isodesmosine Formation:
    Natural Product Communications, 2019
    Co-Authors: Nao Tanaka, Toyonobu Usuki
    Abstract:

    Isodesmosine is a pyridinium amino acid that contributes to elastin’s crosslinking structure. It is known to form by condensation and aromatization of 3 allysines and 1 lysine, preceded by previous...

  • total synthesis of Isodesmosine by stepwise regioselective negishi and sonogashira cross coupling reactions
    European Journal of Organic Chemistry, 2015
    Co-Authors: Yohei Koseki, Takanori Sugimura, Keita Ogawa, Rina Suzuki, Haruka Yamada, Yoshiro Masuyama, Noriyuki Suzuki, Yong Y Lin, Toyonobu Usuki
    Abstract:

    Isodesmosine is a crosslinking pyridinium amino acid of elastin and is an attractive biomarker for the diagnosis of chronic obstructive pulmonary disease (COPD). In this paper, we describe the total synthesis of Isodesmosine. The key features of this synthesis are stepwise and regioselective palladium-catalyzed Negishi and Sonogashira cross-coupling reactions for efficient introduction of amino acid segments on the pyridine ring.

  • Total Synthesis of Isodesmosine by Stepwise, Regioselective Negishi and Sonogashira Cross‐Coupling Reactions
    European Journal of Organic Chemistry, 2015
    Co-Authors: Yohei Koseki, Takanori Sugimura, Keita Ogawa, Rina Suzuki, Haruka Yamada, Yoshiro Masuyama, Noriyuki Suzuki, Toyonobu Usuki
    Abstract:

    Isodesmosine is a crosslinking pyridinium amino acid of elastin and is an attractive biomarker for the diagnosis of chronic obstructive pulmonary disease (COPD). In this paper, we describe the total synthesis of Isodesmosine. The key features of this synthesis are stepwise and regioselective palladium-catalyzed Negishi and Sonogashira cross-coupling reactions for efficient introduction of amino acid segments on the pyridine ring.

Yohei Koseki - One of the best experts on this subject based on the ideXlab platform.

Yong Y Lin - One of the best experts on this subject based on the ideXlab platform.

  • Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
    Annals of the American Thoracic Society, 2016
    Co-Authors: Gerard M Turino, Jerome O. Cantor, Yong Y Lin
    Abstract:

    Biomarkers of pathogenesis in chronic obstructive pulmonary disease (COPD) can significantly accelerate drug development. In COPD related to alpha-1 antitrypsin deficiency, the role of neutrophil elastase and its inhibition by alpha-1 antitrypsin protein focused interest on elastin degradation and the development of pulmonary emphysema. Amino acids desmosine and Isodesmosine are unique cross-links in mature elastin fibers and can serve as biomarkers of elastin degradation when measured in body fluids. This review gives a perspective on what has been learned by the earliest measurements of desmosine and Isodesmosine followed by later studies using methods of increased sensitivity and specificity and the meaning for developing new therapies. Also included are brief statements on the biomarkers fibrinogen, CC-16, and Aa-Val-360 in COPD.

  • total synthesis of Isodesmosine by stepwise regioselective negishi and sonogashira cross coupling reactions
    European Journal of Organic Chemistry, 2015
    Co-Authors: Yohei Koseki, Takanori Sugimura, Keita Ogawa, Rina Suzuki, Haruka Yamada, Yoshiro Masuyama, Noriyuki Suzuki, Yong Y Lin, Toyonobu Usuki
    Abstract:

    Isodesmosine is a crosslinking pyridinium amino acid of elastin and is an attractive biomarker for the diagnosis of chronic obstructive pulmonary disease (COPD). In this paper, we describe the total synthesis of Isodesmosine. The key features of this synthesis are stepwise and regioselective palladium-catalyzed Negishi and Sonogashira cross-coupling reactions for efficient introduction of amino acid segments on the pyridine ring.

  • Stable deuterium internal standard for the isotope-dilution LC–MS/MS analysis of elastin degradation
    Analytical biochemistry, 2013
    Co-Authors: Gerard M Turino, Toyonobu Usuki, Takahiro Hayashi, Hiroto Yanuma, Yong Y Lin
    Abstract:

    Abstract Chemical synthesis of the deuterium isotope desmosine-d 4 has been achieved. This isotopic compound possesses all four deuterium atoms at the alkanyl carbons of the alkyl amino acid substitution in the desmosine molecule and is stable toward acid hydrolysis; this is required in the measurement of two crosslinking molecules, desmosine and Isodesmosine, as biomarkers of elastic tissue degradation. The degradation of elastin occurs in several widely prevalent diseases. The synthesized desmosine-d 4 is used as the internal standard to develop an accurate and sensitive isotope-dilution liquid chromatography–tandem mass spectrometry analysis, which can serve as a generalized method for an accurate analysis of desmosine and Isodesmosine as biomarkers in many types of biological tissues involving elastin degradation.

  • Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease.
    American journal of respiratory and critical care medicine, 2011
    Co-Authors: Gerard M Turino, Jerome O. Cantor, Yong Y Lin, Maurizio Luisetti
    Abstract:

    Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide and is now the third leading cause of death in the United States. There is a lack of therapies that can stop progression of the disease and improve survival. New drug discovery can be aided by the development of biomarkers, which can act as indicators of severity in the course of the disease and responses to therapy. This perspective brings together the laboratory and clinical evidence, which suggest that elastin degradation products can fulfill the need for such a biomarker. Elastin is a recognized target for injury in COPD. The amino acids desmosine and Isodesmosine exist only in matrix elastin; can be measured specifically and sensitively in plasma, urine, and sputum; and indicate changes in the systemic balance between elastase activity and elastase inhibition brought on by the systemic inflammatory state. The biomarker levels in sputum reflect the state of elastin degradation in the lung specifically. Clinical data accumulated over several decades indicate correlations of desmosine and Isodesmosine levels with COPD of varying severity and responses to therapy.

  • The effect of tiotropium therapy on markers of elastin degradation in COPD
    Respiratory research, 2009
    Co-Authors: Yong Y Lin, Lori Tartell, Gerard M Turino
    Abstract:

    Background Desmosine and Isodesmosine (D/I) are cross-linking amino acids which are present only in mature elastin. Changes in their concentration in body fluids indicate changes in elastin degradation and can be a reflection of tissue elastase activity. This study was undertaken to determine whether continuous therapy with the long-acting bronchodilator Tiotropium bromide (TTP) could result in reductions in D/I as measured by mass spectrometry in plasma, urine and sputum.

Takanori Sugimura - One of the best experts on this subject based on the ideXlab platform.

Keita Ogawa - One of the best experts on this subject based on the ideXlab platform.